IQVIA Holdings Inc IQV

NYSE US Health Care Life Sciences Tools & Services

$270.37 ▼ -1.69% ($-4.65)

Index member: S&P 500

Open $274.90

Prev Close $275.02

Day Range $269.43 – $274.90

52W Range $154.50 – $277.40

Market Cap $44.35B

P/E (TTM) 32.43

Beta 1.18

EPS (TTM) $8.07

📋 Company Profile

Industry	Life Sciences Tools & Services
Sector	Health Care
Country	US
Exchange	NEW YORK STOCK EXCHANGE, INC.
Currency	USD
IPO Date	2013-05-09
Shares Out.	164,600,000
Website	ir.iqvia.com/ ↗
Phone	18009279800
Employees	94,000
Revenue	$4.37B
Gross Profit	$1.44B
Net Income	$258.0M
Free Cash Flow	$2.18B
Total Assets	$29.88B
Total Liabilities	$23.58B
Equity	$6.30B

About IQVIA Holdings Inc

Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.

IQVIA Holdings Inc is a publicly traded company under the ticker symbol IQV on the NEW YORK STOCK EXCHANGE, INC., operating in the Life Sciences Tools & Services industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.